Works matching DE "GERON Corp."
1
- Nature Medicine, 2013, v. 19, n. 1, p. 6, doi. 10.1038/nm0113-6
- Article
2
- Nature Medicine, 2009, v. 15, n. 3, p. 224, doi. 10.1038/nm0309-224a
- Article
3
- Nature Medicine, 2009, v. 15, n. 3, p. 228, doi. 10.1038/nm0309-228
- Article
4
- Xenotransplantation, 2004, v. 11, n. 5, p. 387, doi. 10.1111/j.1399-3089.2004.00161.x
- Article
5
- Juridica International, 2011, v. 18, p. 94
- Article
6
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 70
- Article
7
- Nature Reviews Drug Discovery, 2010, v. 9, n. 11, p. 828, doi. 10.1038/nrd3317
- Article
8
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 182, doi. 10.1038/nrd2848
- Article
9
- Eye Care Review, 2009, v. 3, n. 1, p. 55
- Article
10
- Nature Biotechnology, 2010, v. 28, n. 10, p. 989, doi. 10.1038/nbt1010-989
- Article
11
- Nature Biotechnology, 2009, v. 27, n. 10, p. 877, doi. 10.1038/nbt1009-877b
- Article
12
- Nature Biotechnology, 2009, v. 27, n. 3, p. 213, doi. 10.1038/nbt0309-213a
- Article
13
- Nature Biotechnology, 2000, v. 18, n. 4, p. 357, doi. 10.1038/74321
- Article
14
- Nature Biotechnology, 1999, v. 17, n. 6, p. 529, doi. 10.1038/9828
- Article
15
- Nature, 1998, v. 396, n. 6707, p. 97, doi. 10.1038/23983
- Article
16
- Molecular Therapy, 2009, v. 17, n. 3, p. 401, doi. 10.1038/mt.2009.20
- Article
17
- Canadian Medical Association Journal (CMAJ), 2010, v. 182, n. 12, p. E584
- Article
18
- Nature, 2001, v. 412, n. 6849, p. 753, doi. 10.1038/35090694
- Article
19
- Nature, 2000, v. 404, n. 6777, p. 439, doi. 10.1038/35006520
- Article
20
- Nature, 1999, v. 399, n. 6732, p. 92, doi. 10.1038/20026
- Article
21
- Science Translational Medicine, 2015, v. 7, n. 278, p. 1, doi. 10.1126/scitranslmed.3010496
- Kamenova, Kalina;
- Caulfield, Timothy
- Article
22
- Kennedy Institute of Ethics Journal, 2012, v. 22, n. 3, p. 243, doi. 10.1353/ken.2012.0013
- Chapman, Audrey R.;
- Scala, Courtney C.
- Article
23
- Nature, 2009, v. 457, n. 7229, p. 516, doi. 10.1038/457516a
- Article
24
- Human Life Review, 2012, v. 38, n. 1, p. 61
- Article
25
- Nature, 2014, v. 510, n. 7503, p. 18, doi. 10.1038/510018a
- Article
26
- Nature, 2011, v. 479, n. 7374, p. 459, doi. 10.1038/479459a
- Article
27
- Nature Biotechnology, 2014, v. 32, n. 4, p. 313, doi. 10.1038/nbt0414-313
- Article
28
- Nature Biotechnology, 2013, v. 31, n. 2, p. 94, doi. 10.1038/nbt0213-94a
- Article
29
- Nature Biotechnology, 2012, v. 30, n. 6, p. 497, doi. 10.1038/nbt.2253
- Scott, Christopher;
- Huggett, Brady
- Article
30
- Nature Biotechnology, 2012, v. 30, n. 1, p. 12, doi. 10.1038/nbt0112-12
- Article
31
- Journal of Intellectual Property Rights, 2005, v. 10, n. 1, p. 84
- Article